FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2171342611> ?p ?o ?g. }

• W2171342611 endingPage "460.e5" @default.
• W2171342611 startingPage "453" @default.
• W2171342611 abstract "Background & AimsSporadic pancreatic neuroendocrine tumors (pNETs) are rare and genetically heterogeneous. Chromosome instability (CIN) has been detected in pNETs from patients with poor outcomes, but no specific genetic factors have been associated with CIN. Mutations in death domain–associated protein gene (DAXX) or ATR-X gene (ATRX) (which both encode proteins involved in chromatin remodeling) have been detected in 40% of pNETs, in association with activation of alternative lengthening of telomeres. We investigated whether loss of DAXX or ATRX, and consequent alternative lengthening of telomeres, are related to CIN in pNETs. We also assessed whether loss of DAXX or ATRX is associated with specific phenotypes of pNETs.MethodsWe collected well-differentiated primary pNET samples from 142 patients at the University Hospital Zurich and from 101 patients at the University Hospital Bern (both located in Switzerland). Clinical follow-up data were obtained for 149 patients from general practitioners and tumor registries. The tumors were reclassified into 3 groups according to the 2010 World Health Organization classification. Samples were analyzed by immunohistochemistry and telomeric fluorescence in situ hybridization. We correlated loss of DAXX, or ATRX, expression, and activation of alternative lengthening of telomeres with data from comparative genomic hybridization array studies, as well as with clinical and pathological features of the tumors and relapse and survival data.ResultsLoss of DAXX or ATRX protein and alternative lengthening of telomeres were associated with CIN in pNETs. Furthermore, loss of DAXX or ATRX correlated with tumor stage and metastasis, reduced time of relapse-free survival, and decreased time of tumor-associated survival.ConclusionsLoss of DAXX or ATRX is associated with CIN in pNETs and shorter survival times of patients. These results support the hypothesis that DAXX- and ATRX-negative tumors are a more aggressive subtype of pNET, and could lead to identification of strategies to target CIN in pancreatic tumors. Sporadic pancreatic neuroendocrine tumors (pNETs) are rare and genetically heterogeneous. Chromosome instability (CIN) has been detected in pNETs from patients with poor outcomes, but no specific genetic factors have been associated with CIN. Mutations in death domain–associated protein gene (DAXX) or ATR-X gene (ATRX) (which both encode proteins involved in chromatin remodeling) have been detected in 40% of pNETs, in association with activation of alternative lengthening of telomeres. We investigated whether loss of DAXX or ATRX, and consequent alternative lengthening of telomeres, are related to CIN in pNETs. We also assessed whether loss of DAXX or ATRX is associated with specific phenotypes of pNETs. We collected well-differentiated primary pNET samples from 142 patients at the University Hospital Zurich and from 101 patients at the University Hospital Bern (both located in Switzerland). Clinical follow-up data were obtained for 149 patients from general practitioners and tumor registries. The tumors were reclassified into 3 groups according to the 2010 World Health Organization classification. Samples were analyzed by immunohistochemistry and telomeric fluorescence in situ hybridization. We correlated loss of DAXX, or ATRX, expression, and activation of alternative lengthening of telomeres with data from comparative genomic hybridization array studies, as well as with clinical and pathological features of the tumors and relapse and survival data. Loss of DAXX or ATRX protein and alternative lengthening of telomeres were associated with CIN in pNETs. Furthermore, loss of DAXX or ATRX correlated with tumor stage and metastasis, reduced time of relapse-free survival, and decreased time of tumor-associated survival. Loss of DAXX or ATRX is associated with CIN in pNETs and shorter survival times of patients. These results support the hypothesis that DAXX- and ATRX-negative tumors are a more aggressive subtype of pNET, and could lead to identification of strategies to target CIN in pancreatic tumors." @default.
• W2171342611 created "2016-06-24" @default.
• W2171342611 creator A5001237179 @default.
• W2171342611 creator A5001299410 @default.
• W2171342611 creator A5032572194 @default.
• W2171342611 creator A5039015144 @default.
• W2171342611 creator A5046167689 @default.
• W2171342611 creator A5050362578 @default.
• W2171342611 creator A5053893534 @default.
• W2171342611 creator A5075107881 @default.
• W2171342611 creator A5075445944 @default.
• W2171342611 creator A5078500681 @default.
• W2171342611 date "2014-02-01" @default.
• W2171342611 modified "2023-10-13" @default.
• W2171342611 title "Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors" @default.
• W2171342611 cites W1964233267 @default.
• W2171342611 cites W1979954231 @default.
• W2171342611 cites W1986009297 @default.
• W2171342611 cites W1986482998 @default.
• W2171342611 cites W1987313324 @default.
• W2171342611 cites W1991168913 @default.
• W2171342611 cites W1999626396 @default.
• W2171342611 cites W2005250386 @default.
• W2171342611 cites W2016236483 @default.
• W2171342611 cites W2023163806 @default.
• W2171342611 cites W2033808368 @default.
• W2171342611 cites W2051727404 @default.
• W2171342611 cites W2080578479 @default.
• W2171342611 cites W2080629063 @default.
• W2171342611 cites W2083122376 @default.
• W2171342611 cites W2084402294 @default.
• W2171342611 cites W2090232354 @default.
• W2171342611 cites W2090388010 @default.
• W2171342611 cites W2103453025 @default.
• W2171342611 cites W2110471374 @default.
• W2171342611 cites W2115686439 @default.
• W2171342611 cites W2117692326 @default.
• W2171342611 cites W2123623100 @default.
• W2171342611 cites W2130272241 @default.
• W2171342611 cites W2145558154 @default.
• W2171342611 cites W2148678333 @default.
• W2171342611 cites W2158233796 @default.
• W2171342611 cites W2158474413 @default.
• W2171342611 doi "https://doi.org/10.1053/j.gastro.2013.10.020" @default.
• W2171342611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24148618" @default.
• W2171342611 hasPublicationYear "2014" @default.
• W2171342611 type Work @default.
• W2171342611 sameAs 2171342611 @default.
• W2171342611 citedByCount "333" @default.
• W2171342611 countsByYear W21713426112014 @default.
• W2171342611 countsByYear W21713426112015 @default.
• W2171342611 countsByYear W21713426112016 @default.
• W2171342611 countsByYear W21713426112017 @default.
• W2171342611 countsByYear W21713426112018 @default.
• W2171342611 countsByYear W21713426112019 @default.
• W2171342611 countsByYear W21713426112020 @default.
• W2171342611 countsByYear W21713426112021 @default.
• W2171342611 countsByYear W21713426112022 @default.
• W2171342611 countsByYear W21713426112023 @default.
• W2171342611 crossrefType "journal-article" @default.
• W2171342611 hasAuthorship W2171342611A5001237179 @default.
• W2171342611 hasAuthorship W2171342611A5001299410 @default.
• W2171342611 hasAuthorship W2171342611A5032572194 @default.
• W2171342611 hasAuthorship W2171342611A5039015144 @default.
• W2171342611 hasAuthorship W2171342611A5046167689 @default.
• W2171342611 hasAuthorship W2171342611A5050362578 @default.
• W2171342611 hasAuthorship W2171342611A5053893534 @default.
• W2171342611 hasAuthorship W2171342611A5075107881 @default.
• W2171342611 hasAuthorship W2171342611A5075445944 @default.
• W2171342611 hasAuthorship W2171342611A5078500681 @default.
• W2171342611 hasBestOaLocation W21713426111 @default.
• W2171342611 hasConcept C104317684 @default.
• W2171342611 hasConcept C126322002 @default.
• W2171342611 hasConcept C143425029 @default.
• W2171342611 hasConcept C143998085 @default.
• W2171342611 hasConcept C177336024 @default.
• W2171342611 hasConcept C178169997 @default.
• W2171342611 hasConcept C2776689207 @default.
• W2171342611 hasConcept C2779066768 @default.
• W2171342611 hasConcept C29512474 @default.
• W2171342611 hasConcept C501734568 @default.
• W2171342611 hasConcept C502942594 @default.
• W2171342611 hasConcept C54355233 @default.
• W2171342611 hasConcept C552990157 @default.
• W2171342611 hasConcept C71924100 @default.
• W2171342611 hasConcept C86339819 @default.
• W2171342611 hasConcept C86803240 @default.
• W2171342611 hasConcept C89380225 @default.
• W2171342611 hasConceptScore W2171342611C104317684 @default.
• W2171342611 hasConceptScore W2171342611C126322002 @default.
• W2171342611 hasConceptScore W2171342611C143425029 @default.
• W2171342611 hasConceptScore W2171342611C143998085 @default.
• W2171342611 hasConceptScore W2171342611C177336024 @default.
• W2171342611 hasConceptScore W2171342611C178169997 @default.
• W2171342611 hasConceptScore W2171342611C2776689207 @default.
• W2171342611 hasConceptScore W2171342611C2779066768 @default.
• W2171342611 hasConceptScore W2171342611C29512474 @default.
• W2171342611 hasConceptScore W2171342611C501734568 @default.

• next